Medical Care
Global Investigational New Drug CDMO Market Research Report 2025
- Jan 17, 26
- ID: 677140
- Pages: 74
- Figures: 75
- Views: 17
This report aims to provide a comprehensive presentation of the global market for Investigational New Drug CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Investigational New Drug CDMO.
The Investigational New Drug CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Investigational New Drug CDMO market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Investigational New Drug CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
Market Segmentation
By Company
Catalent, Inc.
Lonza
Recipharm AB
Siegfried Holding AG
Patheon Inc.
Covance
IQVIA Holdings Inc.
Cambrex Corporation
Charles River Laboratories International, Inc.
Syneous Health
Segment by Type
Small Molecule
Large Molecule
Segment by End User
Pharmaceutical Companies
Biotech Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Investigational New Drug CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Investigational New Drug CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Investigational New Drug CDMO market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Investigational New Drug CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
Market Segmentation
By Company
Catalent, Inc.
Lonza
Recipharm AB
Siegfried Holding AG
Patheon Inc.
Covance
IQVIA Holdings Inc.
Cambrex Corporation
Charles River Laboratories International, Inc.
Syneous Health
Segment by Type
Small Molecule
Large Molecule
Segment by End User
Pharmaceutical Companies
Biotech Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Investigational New Drug CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Investigational New Drug CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule
1.2.3 Large Molecule
1.3 Market by End User
1.3.1 Global Investigational New Drug CDMO Market Growth by End User: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Investigational New Drug CDMO Market Perspective (2020-2031)
2.2 Global Investigational New Drug CDMO Growth Trends by Region
2.2.1 Global Investigational New Drug CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Investigational New Drug CDMO Historic Market Size by Region (2020-2025)
2.2.3 Investigational New Drug CDMO Forecasted Market Size by Region (2026-2031)
2.3 Investigational New Drug CDMO Market Dynamics
2.3.1 Investigational New Drug CDMO Industry Trends
2.3.2 Investigational New Drug CDMO Market Drivers
2.3.3 Investigational New Drug CDMO Market Challenges
2.3.4 Investigational New Drug CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Investigational New Drug CDMO Players by Revenue
3.1.1 Global Top Investigational New Drug CDMO Players by Revenue (2020-2025)
3.1.2 Global Investigational New Drug CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Investigational New Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Investigational New Drug CDMO Revenue
3.4 Global Investigational New Drug CDMO Market Concentration Ratio
3.4.1 Global Investigational New Drug CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Investigational New Drug CDMO Revenue in 2024
3.5 Global Key Players of Investigational New Drug CDMO Head office and Area Served
3.6 Global Key Players of Investigational New Drug CDMO, Product and Application
3.7 Global Key Players of Investigational New Drug CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Investigational New Drug CDMO Breakdown Data by Type
4.1 Global Investigational New Drug CDMO Historic Market Size by Type (2020-2025)
4.2 Global Investigational New Drug CDMO Forecasted Market Size by Type (2026-2031)
5 Investigational New Drug CDMO Breakdown Data by End User
5.1 Global Investigational New Drug CDMO Historic Market Size by End User (2020-2025)
5.2 Global Investigational New Drug CDMO Forecasted Market Size by End User (2026-2031)
6 North America
6.1 North America Investigational New Drug CDMO Market Size (2020-2031)
6.2 North America Investigational New Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Investigational New Drug CDMO Market Size by Country (2020-2025)
6.4 North America Investigational New Drug CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Investigational New Drug CDMO Market Size (2020-2031)
7.2 Europe Investigational New Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Investigational New Drug CDMO Market Size by Country (2020-2025)
7.4 Europe Investigational New Drug CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Investigational New Drug CDMO Market Size (2020-2031)
8.2 Asia-Pacific Investigational New Drug CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Investigational New Drug CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Investigational New Drug CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Investigational New Drug CDMO Market Size (2020-2031)
9.2 Latin America Investigational New Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Investigational New Drug CDMO Market Size by Country (2020-2025)
9.4 Latin America Investigational New Drug CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Investigational New Drug CDMO Market Size (2020-2031)
10.2 Middle East & Africa Investigational New Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Investigational New Drug CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Investigational New Drug CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent, Inc.
11.1.1 Catalent, Inc. Company Details
11.1.2 Catalent, Inc. Business Overview
11.1.3 Catalent, Inc. Investigational New Drug CDMO Introduction
11.1.4 Catalent, Inc. Revenue in Investigational New Drug CDMO Business (2020-2025)
11.1.5 Catalent, Inc. Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Investigational New Drug CDMO Introduction
11.2.4 Lonza Revenue in Investigational New Drug CDMO Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Recipharm AB
11.3.1 Recipharm AB Company Details
11.3.2 Recipharm AB Business Overview
11.3.3 Recipharm AB Investigational New Drug CDMO Introduction
11.3.4 Recipharm AB Revenue in Investigational New Drug CDMO Business (2020-2025)
11.3.5 Recipharm AB Recent Development
11.4 Siegfried Holding AG
11.4.1 Siegfried Holding AG Company Details
11.4.2 Siegfried Holding AG Business Overview
11.4.3 Siegfried Holding AG Investigational New Drug CDMO Introduction
11.4.4 Siegfried Holding AG Revenue in Investigational New Drug CDMO Business (2020-2025)
11.4.5 Siegfried Holding AG Recent Development
11.5 Patheon Inc.
11.5.1 Patheon Inc. Company Details
11.5.2 Patheon Inc. Business Overview
11.5.3 Patheon Inc. Investigational New Drug CDMO Introduction
11.5.4 Patheon Inc. Revenue in Investigational New Drug CDMO Business (2020-2025)
11.5.5 Patheon Inc. Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance Investigational New Drug CDMO Introduction
11.6.4 Covance Revenue in Investigational New Drug CDMO Business (2020-2025)
11.6.5 Covance Recent Development
11.7 IQVIA Holdings Inc.
11.7.1 IQVIA Holdings Inc. Company Details
11.7.2 IQVIA Holdings Inc. Business Overview
11.7.3 IQVIA Holdings Inc. Investigational New Drug CDMO Introduction
11.7.4 IQVIA Holdings Inc. Revenue in Investigational New Drug CDMO Business (2020-2025)
11.7.5 IQVIA Holdings Inc. Recent Development
11.8 Cambrex Corporation
11.8.1 Cambrex Corporation Company Details
11.8.2 Cambrex Corporation Business Overview
11.8.3 Cambrex Corporation Investigational New Drug CDMO Introduction
11.8.4 Cambrex Corporation Revenue in Investigational New Drug CDMO Business (2020-2025)
11.8.5 Cambrex Corporation Recent Development
11.9 Charles River Laboratories International, Inc.
11.9.1 Charles River Laboratories International, Inc. Company Details
11.9.2 Charles River Laboratories International, Inc. Business Overview
11.9.3 Charles River Laboratories International, Inc. Investigational New Drug CDMO Introduction
11.9.4 Charles River Laboratories International, Inc. Revenue in Investigational New Drug CDMO Business (2020-2025)
11.9.5 Charles River Laboratories International, Inc. Recent Development
11.10 Syneous Health
11.10.1 Syneous Health Company Details
11.10.2 Syneous Health Business Overview
11.10.3 Syneous Health Investigational New Drug CDMO Introduction
11.10.4 Syneous Health Revenue in Investigational New Drug CDMO Business (2020-2025)
11.10.5 Syneous Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Investigational New Drug CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule
1.2.3 Large Molecule
1.3 Market by End User
1.3.1 Global Investigational New Drug CDMO Market Growth by End User: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Investigational New Drug CDMO Market Perspective (2020-2031)
2.2 Global Investigational New Drug CDMO Growth Trends by Region
2.2.1 Global Investigational New Drug CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Investigational New Drug CDMO Historic Market Size by Region (2020-2025)
2.2.3 Investigational New Drug CDMO Forecasted Market Size by Region (2026-2031)
2.3 Investigational New Drug CDMO Market Dynamics
2.3.1 Investigational New Drug CDMO Industry Trends
2.3.2 Investigational New Drug CDMO Market Drivers
2.3.3 Investigational New Drug CDMO Market Challenges
2.3.4 Investigational New Drug CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Investigational New Drug CDMO Players by Revenue
3.1.1 Global Top Investigational New Drug CDMO Players by Revenue (2020-2025)
3.1.2 Global Investigational New Drug CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Investigational New Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Investigational New Drug CDMO Revenue
3.4 Global Investigational New Drug CDMO Market Concentration Ratio
3.4.1 Global Investigational New Drug CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Investigational New Drug CDMO Revenue in 2024
3.5 Global Key Players of Investigational New Drug CDMO Head office and Area Served
3.6 Global Key Players of Investigational New Drug CDMO, Product and Application
3.7 Global Key Players of Investigational New Drug CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Investigational New Drug CDMO Breakdown Data by Type
4.1 Global Investigational New Drug CDMO Historic Market Size by Type (2020-2025)
4.2 Global Investigational New Drug CDMO Forecasted Market Size by Type (2026-2031)
5 Investigational New Drug CDMO Breakdown Data by End User
5.1 Global Investigational New Drug CDMO Historic Market Size by End User (2020-2025)
5.2 Global Investigational New Drug CDMO Forecasted Market Size by End User (2026-2031)
6 North America
6.1 North America Investigational New Drug CDMO Market Size (2020-2031)
6.2 North America Investigational New Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Investigational New Drug CDMO Market Size by Country (2020-2025)
6.4 North America Investigational New Drug CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Investigational New Drug CDMO Market Size (2020-2031)
7.2 Europe Investigational New Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Investigational New Drug CDMO Market Size by Country (2020-2025)
7.4 Europe Investigational New Drug CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Investigational New Drug CDMO Market Size (2020-2031)
8.2 Asia-Pacific Investigational New Drug CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Investigational New Drug CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Investigational New Drug CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Investigational New Drug CDMO Market Size (2020-2031)
9.2 Latin America Investigational New Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Investigational New Drug CDMO Market Size by Country (2020-2025)
9.4 Latin America Investigational New Drug CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Investigational New Drug CDMO Market Size (2020-2031)
10.2 Middle East & Africa Investigational New Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Investigational New Drug CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Investigational New Drug CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent, Inc.
11.1.1 Catalent, Inc. Company Details
11.1.2 Catalent, Inc. Business Overview
11.1.3 Catalent, Inc. Investigational New Drug CDMO Introduction
11.1.4 Catalent, Inc. Revenue in Investigational New Drug CDMO Business (2020-2025)
11.1.5 Catalent, Inc. Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Investigational New Drug CDMO Introduction
11.2.4 Lonza Revenue in Investigational New Drug CDMO Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Recipharm AB
11.3.1 Recipharm AB Company Details
11.3.2 Recipharm AB Business Overview
11.3.3 Recipharm AB Investigational New Drug CDMO Introduction
11.3.4 Recipharm AB Revenue in Investigational New Drug CDMO Business (2020-2025)
11.3.5 Recipharm AB Recent Development
11.4 Siegfried Holding AG
11.4.1 Siegfried Holding AG Company Details
11.4.2 Siegfried Holding AG Business Overview
11.4.3 Siegfried Holding AG Investigational New Drug CDMO Introduction
11.4.4 Siegfried Holding AG Revenue in Investigational New Drug CDMO Business (2020-2025)
11.4.5 Siegfried Holding AG Recent Development
11.5 Patheon Inc.
11.5.1 Patheon Inc. Company Details
11.5.2 Patheon Inc. Business Overview
11.5.3 Patheon Inc. Investigational New Drug CDMO Introduction
11.5.4 Patheon Inc. Revenue in Investigational New Drug CDMO Business (2020-2025)
11.5.5 Patheon Inc. Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance Investigational New Drug CDMO Introduction
11.6.4 Covance Revenue in Investigational New Drug CDMO Business (2020-2025)
11.6.5 Covance Recent Development
11.7 IQVIA Holdings Inc.
11.7.1 IQVIA Holdings Inc. Company Details
11.7.2 IQVIA Holdings Inc. Business Overview
11.7.3 IQVIA Holdings Inc. Investigational New Drug CDMO Introduction
11.7.4 IQVIA Holdings Inc. Revenue in Investigational New Drug CDMO Business (2020-2025)
11.7.5 IQVIA Holdings Inc. Recent Development
11.8 Cambrex Corporation
11.8.1 Cambrex Corporation Company Details
11.8.2 Cambrex Corporation Business Overview
11.8.3 Cambrex Corporation Investigational New Drug CDMO Introduction
11.8.4 Cambrex Corporation Revenue in Investigational New Drug CDMO Business (2020-2025)
11.8.5 Cambrex Corporation Recent Development
11.9 Charles River Laboratories International, Inc.
11.9.1 Charles River Laboratories International, Inc. Company Details
11.9.2 Charles River Laboratories International, Inc. Business Overview
11.9.3 Charles River Laboratories International, Inc. Investigational New Drug CDMO Introduction
11.9.4 Charles River Laboratories International, Inc. Revenue in Investigational New Drug CDMO Business (2020-2025)
11.9.5 Charles River Laboratories International, Inc. Recent Development
11.10 Syneous Health
11.10.1 Syneous Health Company Details
11.10.2 Syneous Health Business Overview
11.10.3 Syneous Health Investigational New Drug CDMO Introduction
11.10.4 Syneous Health Revenue in Investigational New Drug CDMO Business (2020-2025)
11.10.5 Syneous Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Investigational New Drug CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule
Table 3. Key Players of Large Molecule
Table 4. Global Investigational New Drug CDMO Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Investigational New Drug CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Investigational New Drug CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Investigational New Drug CDMO Market Share by Region (2020-2025)
Table 8. Global Investigational New Drug CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Investigational New Drug CDMO Market Share by Region (2026-2031)
Table 10. Investigational New Drug CDMO Market Trends
Table 11. Investigational New Drug CDMO Market Drivers
Table 12. Investigational New Drug CDMO Market Challenges
Table 13. Investigational New Drug CDMO Market Restraints
Table 14. Global Investigational New Drug CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Investigational New Drug CDMO Market Share by Players (2020-2025)
Table 16. Global Top Investigational New Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Investigational New Drug CDMO as of 2024)
Table 17. Ranking of Global Top Investigational New Drug CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Investigational New Drug CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Investigational New Drug CDMO, Headquarters and Area Served
Table 20. Global Key Players of Investigational New Drug CDMO, Product and Application
Table 21. Global Key Players of Investigational New Drug CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Investigational New Drug CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Investigational New Drug CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Investigational New Drug CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Investigational New Drug CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Investigational New Drug CDMO Market Size by End User (2020-2025) & (US$ Million)
Table 28. Global Investigational New Drug CDMO Revenue Market Share by End User (2020-2025)
Table 29. Global Investigational New Drug CDMO Forecasted Market Size by End User (2026-2031) & (US$ Million)
Table 30. Global Investigational New Drug CDMO Revenue Market Share by End User (2026-2031)
Table 31. North America Investigational New Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Investigational New Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Investigational New Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Investigational New Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Investigational New Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Investigational New Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Investigational New Drug CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Investigational New Drug CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Investigational New Drug CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Investigational New Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Investigational New Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Investigational New Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Investigational New Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Investigational New Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Investigational New Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Catalent, Inc. Company Details
Table 47. Catalent, Inc. Business Overview
Table 48. Catalent, Inc. Investigational New Drug CDMO Product
Table 49. Catalent, Inc. Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 50. Catalent, Inc. Recent Development
Table 51. Lonza Company Details
Table 52. Lonza Business Overview
Table 53. Lonza Investigational New Drug CDMO Product
Table 54. Lonza Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 55. Lonza Recent Development
Table 56. Recipharm AB Company Details
Table 57. Recipharm AB Business Overview
Table 58. Recipharm AB Investigational New Drug CDMO Product
Table 59. Recipharm AB Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 60. Recipharm AB Recent Development
Table 61. Siegfried Holding AG Company Details
Table 62. Siegfried Holding AG Business Overview
Table 63. Siegfried Holding AG Investigational New Drug CDMO Product
Table 64. Siegfried Holding AG Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 65. Siegfried Holding AG Recent Development
Table 66. Patheon Inc. Company Details
Table 67. Patheon Inc. Business Overview
Table 68. Patheon Inc. Investigational New Drug CDMO Product
Table 69. Patheon Inc. Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 70. Patheon Inc. Recent Development
Table 71. Covance Company Details
Table 72. Covance Business Overview
Table 73. Covance Investigational New Drug CDMO Product
Table 74. Covance Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 75. Covance Recent Development
Table 76. IQVIA Holdings Inc. Company Details
Table 77. IQVIA Holdings Inc. Business Overview
Table 78. IQVIA Holdings Inc. Investigational New Drug CDMO Product
Table 79. IQVIA Holdings Inc. Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 80. IQVIA Holdings Inc. Recent Development
Table 81. Cambrex Corporation Company Details
Table 82. Cambrex Corporation Business Overview
Table 83. Cambrex Corporation Investigational New Drug CDMO Product
Table 84. Cambrex Corporation Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 85. Cambrex Corporation Recent Development
Table 86. Charles River Laboratories International, Inc. Company Details
Table 87. Charles River Laboratories International, Inc. Business Overview
Table 88. Charles River Laboratories International, Inc. Investigational New Drug CDMO Product
Table 89. Charles River Laboratories International, Inc. Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 90. Charles River Laboratories International, Inc. Recent Development
Table 91. Syneous Health Company Details
Table 92. Syneous Health Business Overview
Table 93. Syneous Health Investigational New Drug CDMO Product
Table 94. Syneous Health Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 95. Syneous Health Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Investigational New Drug CDMO Picture
Figure 2. Global Investigational New Drug CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Investigational New Drug CDMO Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule Features
Figure 5. Large Molecule Features
Figure 6. Global Investigational New Drug CDMO Market Size by End User (2020-2031) & (US$ Million)
Figure 7. Global Investigational New Drug CDMO Market Share by End User: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Biotech Companies Case Studies
Figure 10. Others Case Studies
Figure 11. Investigational New Drug CDMO Report Years Considered
Figure 12. Global Investigational New Drug CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Investigational New Drug CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Investigational New Drug CDMO Market Share by Region: 2024 VS 2031
Figure 15. Global Investigational New Drug CDMO Market Share by Players in 2024
Figure 16. Global Top Investigational New Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Investigational New Drug CDMO as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Investigational New Drug CDMO Revenue in 2024
Figure 18. North America Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Investigational New Drug CDMO Market Share by Country (2020-2031)
Figure 20. United States Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Investigational New Drug CDMO Market Share by Country (2020-2031)
Figure 24. Germany Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Investigational New Drug CDMO Market Share by Region (2020-2031)
Figure 32. China Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Investigational New Drug CDMO Market Share by Country (2020-2031)
Figure 40. Mexico Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Investigational New Drug CDMO Market Share by Country (2020-2031)
Figure 44. Turkey Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Catalent, Inc. Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 48. Lonza Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 49. Recipharm AB Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 50. Siegfried Holding AG Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 51. Patheon Inc. Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 52. Covance Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 53. IQVIA Holdings Inc. Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 54. Cambrex Corporation Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 55. Charles River Laboratories International, Inc. Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 56. Syneous Health Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Investigational New Drug CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule
Table 3. Key Players of Large Molecule
Table 4. Global Investigational New Drug CDMO Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Investigational New Drug CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Investigational New Drug CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Investigational New Drug CDMO Market Share by Region (2020-2025)
Table 8. Global Investigational New Drug CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Investigational New Drug CDMO Market Share by Region (2026-2031)
Table 10. Investigational New Drug CDMO Market Trends
Table 11. Investigational New Drug CDMO Market Drivers
Table 12. Investigational New Drug CDMO Market Challenges
Table 13. Investigational New Drug CDMO Market Restraints
Table 14. Global Investigational New Drug CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Investigational New Drug CDMO Market Share by Players (2020-2025)
Table 16. Global Top Investigational New Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Investigational New Drug CDMO as of 2024)
Table 17. Ranking of Global Top Investigational New Drug CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Investigational New Drug CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Investigational New Drug CDMO, Headquarters and Area Served
Table 20. Global Key Players of Investigational New Drug CDMO, Product and Application
Table 21. Global Key Players of Investigational New Drug CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Investigational New Drug CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Investigational New Drug CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Investigational New Drug CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Investigational New Drug CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Investigational New Drug CDMO Market Size by End User (2020-2025) & (US$ Million)
Table 28. Global Investigational New Drug CDMO Revenue Market Share by End User (2020-2025)
Table 29. Global Investigational New Drug CDMO Forecasted Market Size by End User (2026-2031) & (US$ Million)
Table 30. Global Investigational New Drug CDMO Revenue Market Share by End User (2026-2031)
Table 31. North America Investigational New Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Investigational New Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Investigational New Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Investigational New Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Investigational New Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Investigational New Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Investigational New Drug CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Investigational New Drug CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Investigational New Drug CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Investigational New Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Investigational New Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Investigational New Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Investigational New Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Investigational New Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Investigational New Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Catalent, Inc. Company Details
Table 47. Catalent, Inc. Business Overview
Table 48. Catalent, Inc. Investigational New Drug CDMO Product
Table 49. Catalent, Inc. Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 50. Catalent, Inc. Recent Development
Table 51. Lonza Company Details
Table 52. Lonza Business Overview
Table 53. Lonza Investigational New Drug CDMO Product
Table 54. Lonza Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 55. Lonza Recent Development
Table 56. Recipharm AB Company Details
Table 57. Recipharm AB Business Overview
Table 58. Recipharm AB Investigational New Drug CDMO Product
Table 59. Recipharm AB Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 60. Recipharm AB Recent Development
Table 61. Siegfried Holding AG Company Details
Table 62. Siegfried Holding AG Business Overview
Table 63. Siegfried Holding AG Investigational New Drug CDMO Product
Table 64. Siegfried Holding AG Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 65. Siegfried Holding AG Recent Development
Table 66. Patheon Inc. Company Details
Table 67. Patheon Inc. Business Overview
Table 68. Patheon Inc. Investigational New Drug CDMO Product
Table 69. Patheon Inc. Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 70. Patheon Inc. Recent Development
Table 71. Covance Company Details
Table 72. Covance Business Overview
Table 73. Covance Investigational New Drug CDMO Product
Table 74. Covance Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 75. Covance Recent Development
Table 76. IQVIA Holdings Inc. Company Details
Table 77. IQVIA Holdings Inc. Business Overview
Table 78. IQVIA Holdings Inc. Investigational New Drug CDMO Product
Table 79. IQVIA Holdings Inc. Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 80. IQVIA Holdings Inc. Recent Development
Table 81. Cambrex Corporation Company Details
Table 82. Cambrex Corporation Business Overview
Table 83. Cambrex Corporation Investigational New Drug CDMO Product
Table 84. Cambrex Corporation Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 85. Cambrex Corporation Recent Development
Table 86. Charles River Laboratories International, Inc. Company Details
Table 87. Charles River Laboratories International, Inc. Business Overview
Table 88. Charles River Laboratories International, Inc. Investigational New Drug CDMO Product
Table 89. Charles River Laboratories International, Inc. Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 90. Charles River Laboratories International, Inc. Recent Development
Table 91. Syneous Health Company Details
Table 92. Syneous Health Business Overview
Table 93. Syneous Health Investigational New Drug CDMO Product
Table 94. Syneous Health Revenue in Investigational New Drug CDMO Business (2020-2025) & (US$ Million)
Table 95. Syneous Health Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Investigational New Drug CDMO Picture
Figure 2. Global Investigational New Drug CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Investigational New Drug CDMO Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule Features
Figure 5. Large Molecule Features
Figure 6. Global Investigational New Drug CDMO Market Size by End User (2020-2031) & (US$ Million)
Figure 7. Global Investigational New Drug CDMO Market Share by End User: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Biotech Companies Case Studies
Figure 10. Others Case Studies
Figure 11. Investigational New Drug CDMO Report Years Considered
Figure 12. Global Investigational New Drug CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Investigational New Drug CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Investigational New Drug CDMO Market Share by Region: 2024 VS 2031
Figure 15. Global Investigational New Drug CDMO Market Share by Players in 2024
Figure 16. Global Top Investigational New Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Investigational New Drug CDMO as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Investigational New Drug CDMO Revenue in 2024
Figure 18. North America Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Investigational New Drug CDMO Market Share by Country (2020-2031)
Figure 20. United States Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Investigational New Drug CDMO Market Share by Country (2020-2031)
Figure 24. Germany Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Investigational New Drug CDMO Market Share by Region (2020-2031)
Figure 32. China Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Investigational New Drug CDMO Market Share by Country (2020-2031)
Figure 40. Mexico Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Investigational New Drug CDMO Market Share by Country (2020-2031)
Figure 44. Turkey Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Investigational New Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Catalent, Inc. Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 48. Lonza Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 49. Recipharm AB Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 50. Siegfried Holding AG Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 51. Patheon Inc. Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 52. Covance Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 53. IQVIA Holdings Inc. Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 54. Cambrex Corporation Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 55. Charles River Laboratories International, Inc. Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 56. Syneous Health Revenue Growth Rate in Investigational New Drug CDMO Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232